Status
Conditions
About
This study seeks to determine the clinical characteristics of young ESUS patients using diagnostic criteria of the Cryptogenic Stroke / ESUS International Working Group, and to determine the rates of stroke recurrence, death, and hospital readmission in a contemporary cohort of young ESUS patients during follow-up of up to 18 months.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Embolic stroke of undetermined source (ESUS) within 60 days, defined as:
Age ≥ 21 to ≤ 50 years
Written informed consent with local regulations governing research in human subjects
Exclusion criteria
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal